Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Mokaleng, Botshelo B ^a   Ebenhan, Thomas ^a,b   Ramesh, Suhas ^c   Govender, Thavendran ^c   Kruger, Hendrik G ^c   Parboosing, Raveen ^d   Hazari, Puja P ^e   Mishra, Anil K ^e   Marjanovic Painter, Biljana ^f   Zeevaart, Jan R ^g   Sathekge, Mike M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b School of Chemistry and Physics   (South Africa)

^c School of Health Sciences Catalysis and Peptide Research Unit Westville Campus   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^f NECSA   (South Africa)

^g NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATE; DEPSIPEPTIDE; DOTA TBIA101 GA 68; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; ANTIINFECTIVE AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM; SINGLE HETEROCYCLIC RINGS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG STABILITY; DRUG SYNTHESIS; ESCHERICHIA COLI INFECTION; FOREARM; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; PEPTIDE SYNTHESIS; RADIOACTIVITY; RADIOCHEMISTRY; SINGLE DRUG DOSE; THIGH; URINARY EXCRETION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MICROBIOLOGY; MUSCLE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

ANIMALS; ANTI-INFECTIVE AGENTS; DEPSIPEPTIDES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; ISOTOPE LABELING; MALE; MICE; MICE, INBRED BALB C; MUSCLES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84933050723     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/284354     Document Type: Article

References (39)

1. G. Malviya and A. Sinore, "Infection and inflammation imaging," Nuclear Medicine and Biology, vol. 41, no. 6, p. 488, 2014.
2. A. Signore, C. Lauri, and F. Galli, "Radiolabelled probes targeting infection and inflammation for personalized medicine," Current Pharmaceutical Design, vol. 20, no. 14, pp. 2338-2345, 2014.
3. M. M. Welling, S. Mongera, A. Lupetti et al., "Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections," Nuclear Medicine and Biology, vol. 29, no. 4, pp. 413-422, 2002.
4. G. Ferro-Flores, F. D. M. Ramírez, L. Meléndez-Alafort, C. A. D. Murphy, and M. Pedraza-López, "Molecular recognition and stability of 99mTc-UBI 29-41 based on experimental and semiempirical results," Applied Radiation and Isotopes, vol. 61, no. 6, pp. 1261-1268, 2004.
5. T. Ebenhan, J. R. Zeevaart, J. D. Venter et al., "Preclinical evaluation of 68Ga-labeled 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging," Journal of Nuclear Medicine, vol. 55, no. 2, pp. 308-314, 2014.
6. J. S. Davies, "The cyclization of peptides and depsipeptides," Journal of Peptide Science, vol. 9, no. 8, pp. 471-501, 2003.
7. V. K. Narayanaswamy, F. Albericio, Y. M. Coovadia et al., "Total synthesis of a depsidomycin analogue by convergent solidphase peptide synthesis and macrolactonization strategy for antitubercular activity," Journal of Peptide Science, vol. 17, no. 10, pp. 683-689, 2011.
8. H. Li, B. Li, H. Song, L. Breydo, I. V. Baskakov, and L.-X. Wang, "Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain," The Journal of Organic Chemistry, vol. 70, no. 24, pp. 9990-9996, 2005.
9. B. Behnam Azad, V. A. Rota, D. Breadner, S. Dhanvantari, and L. G. Luyt, "Design, synthesis and in vitro characterization of Glucagon-Like Peptide-1 derivatives for pancreatic beta cell imaging by SPECT," Bioorganic and Medicinal Chemistry, vol. 18, no. 3, pp. 1265-1272, 2010.
10. S. M. Mandal, L. Migliolo, and O. L. Franco, "The use of MALDI-TOF-MS and in Silico studies for determination of antimicrobial peptides' affinity to bacterial cells," Journal of the American Society for Mass Spectrometry, vol. 23,no. 11,pp. 1939-1948, 2012.
11. D. A. Scudiero, R. H. Shoemaker, K. D. Paull et al., "Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines," Cancer Research, vol. 48, no. 17, pp. 4827-4833, 1988.
12. W. A. P. Breeman, M. de Jong, E. de Blois, B. F. Bernard, M. Konijnenberg, and E. P. Krenning, "Radiolabelling DOTApeptides with 68Ga," European Journal of NuclearMedicine and Molecular Imaging, vol. 32, no. 4, pp. 478-485, 2005.
13. D. D. RossouwandW. A. P. Breeman, "Scaled-up radiolabelling ofDOTATATEwith68Ga eluted froma SnO2-based68Ge/68Ga generator," Applied Radiation and Isotopes, vol. 70,no. 1, pp. 171-175, 2012.
14. M. Ocak, M. Antretter, R. Knopp et al., "Full automation of 68Ga labelling of DOTA-peptides including cation exchange prepurification," Applied Radiation and Isotopes, vol. 68, no. 2, pp. 297-302, 2010.
15. D. Billot-Klein, D. Shlaes, D. Bryant et al., "Presence of UDPN-Acetylmuramyl-Hexapeptides and-Heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin," Journal of Bacteriology, vol. 179, no. 15, pp. 4684-4688, 1997.
16. I. L. Karle, D. Ranganathan, M. G. Kumar, and R. Nagaraj, "Design, synthesis, conformational and membrane ion transport studies of proline-adamantane hybrid cyclic depsipeptides," Biopolymers, vol. 89, no. 5, pp. 471-478, 2008.
17. L. Zhang, A. Rozek, and R. E. W. Hancock, "Interaction of cationic antimicrobial peptides with model membrane," The Journal of Biological Chemistry, vol. 276, no. 21, pp. 35714-35722, 2001.
18. L. M. de León-Rodriguez, Z. Kovacs, G. R. Dieckmann, and A. D. Sherry, "Solid-phase synthesis of DOTA-peptides," Chemistry, vol. 10, no. 5, pp. 1149-1155, 2004.
19. M. S. Akhtar, M. B. Imran, M. A. Nadeem, and A. Shahid, "Antimicrobial peptides as infection imaging agents: better than radiolabeled antibiotics," International Journal of Peptides, vol. 2012, Article ID965238, 19 pages, 2012.
20. T. Ujula, S. Salomäki, P. Virsu et al., "Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis," Nuclear Medicine and Biology, vol. 36, no. 6, pp. 631-641, 2009.
21. L. Yang, T. M. Weiss, R. I. Lehrer, and H. W. Huang, "Crystallization of antimicrobial pores in membranes: magainin and protegrin," Biophysical Journal, vol. 79, no. 4, pp. 2002-2009, 2000.
22. H. W. Huang, "Action of antimicrobial peptides: two-state model," Biochemistry, vol. 39, no. 29, pp. 8347-8352, 2000.
23. E. de Blois, H. S. Chan, C. Naidoo, D. Prince, E. P. Krenning, and W. A. P. Breeman, "Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTApeptides," Applied Radiation and Isotopes, vol. 69,no. 2, pp. 308-315, 2011.
24. T. Ebenhan, N. Chadwick, M. M. Sathekge et al., "Peptide synthesis, characterization and 68Ga-radiolabeling of NOTAconjugated ubiquicidin fragments for prospective infection imaging with PET/CT," Nuclear Medicine and Biology, vol. 41, no. 5, pp. 390-400, 2014.
25. D. Mueller, I. Klette, R. P. Baum, M. Gottschaldt, M. K. Schultz, and W. A. P. Breeman, "Simplified NaCl based 68Ga concentration and labeling procedure for rapid synthesis of 68Ga radiopharmaceuticals in high radiochemical purity," Bioconjugate Chemistry, vol. 23, no. 8, pp. 1712-1717, 2012.
26. R. Lesche, G. Kettschau, A. V. Gromov et al., "Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostatespecificmembrane antigen for PET imaging of prostate cancer," European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 1, pp. 89-101, 2014.
27. A. R. Jalilian, H. Yousefnia, K. Shafaii, A. Novinrouz, and A. A. Rajamand, "Preparation and biodistribution studies of a radiogallium-acetylacetonate bis (thiosemicarbazone) complex in tumor-bearing rodents," Iranian Journal of Pharmaceutical Research, vol. 11, no. 2, pp. 523-531, 2012.
28. B. Y. Yang, J. M. Jeong, Y. J. Kim et al., "Formulation of 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study," Nuclear Medicine and Biology, vol. 37, no. 2, pp. 149-155, 2010.
29. A.Fontes,M. I.M. Prata, C. F. Geraldes, and J. P. André, "Ga(III) chelates of amphiphilic DOTA-based ligands: synthetic route and in vitro and in vivo studies," Nuclear Medicine and Biology, vol. 38, no. 3, pp. 363-370, 2011.
30. T. Ebenhan, O. Gheysens, G. E. M. Maguire et al., "[68Ga]NOTA-UBI-PET: a host-independent targeted method to non-invasively imaging of bacterial infection-preclinical evaluation in small animal models," (WFNMB accepted abstract publication), 2014.
31. M. S. Akhtar, J. Iqbal, M. A. Khan et al., "99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection," Journal of Nuclear Medicine, vol. 45, no. 5, pp. 849-856, 2004.
32. J. Silvola, A.Autio, P. Luoto, S. Jalkanen, and A. Roivainen, "Preliminary evaluation of novel 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1," Clinical Physiology and Functional Imaging, vol. 30, no. 1, pp. 75-78, 2010.
33. L.Hoigebazar, J. M. Jeong, M. K.Hong et al., "Synthesis of 68Galabeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers," Bioorganic & Medicinal Chemistry, vol. 19, no. 7, pp. 2176-2181, 2011.
34. C. Cocito, M. Di Giambattista, E. Nyssen, and P. Vannuffel, "Inhibition of protein synthesis by streptogramins and related antibiotics,"The Journal of Antimicrobial Chemotherapy, vol. 39, supplement 1, pp. 7-13, 1997.
35. J.-L.Thomassin, J. R. Brannon, J. Kaiser, S. Gruenheid, and H. le Moual, "Enterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptides," Gut Microbes, vol. 3, no. 6, pp. 556-561, 2012.
36. J.-L. Thomassin, J. R. Brannon, B. F. Gibbs, S. Gruenheid, and H. Le Moual, "OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37," Infection and Immunity, vol. 80, no. 2, pp. 483-492, 2012.
37. B. Sperandio, B. Regnault, J. Guo et al., "Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression," The Journal of Experimental Medicine, vol. 205, no. 5, pp. 1121-1132, 2008.
38. D. Islam, L. Bandholtz, J.Nilsson et al., "Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanismwith bacterialDNA as a potential regulator," Nature Medicine, vol. 7, no. 2, pp. 180-185, 2001.
39. H. LeMoual, J.-L.Thomassin, and J. R. Brannon, "Antimicrobial peptidesas an alternative approach to treat bacterial infections," Journal of Clinical & Cellular Immunology, vol. S13, article 004, 2013.